Alaa Abdullah El-Sadieque

Ms. Alaa Abdullah El-Sadieque

Alexandria University Cancer Research Cluster, Alexandria, Al Iskandarīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MSMamdouh M. Shawki
Mamdouh M. Shawki
Alaa Abdullah El-SadiequeAlaa Abdullah El-Sadieque
Alaa Abdullah El-Sadieque
SESeham Elabd
Seham Elabd
MMMaisa Moustafa
Maisa Moustafa
Cancer remains a leading cause of death worldwide, despite extraordinary progress. So, new cancer treatment modalities are needed. Tumor-treating fields (TTFs) use low-intensity, intermediate-frequency alternating electric fields with reported cancer anti-mitotic properties. Moreover, nanomedicine is a promising therapy option for cancer. Numerous cancer types have been treated with nanoparticles, but zinc oxide nanoparticles (ZnO NPs) exhibit biocompatibility. Here, we investigate the activity of TTFs, a sub-lethal dose of ZnO NPs, and their combination on hepatocellular carcinoma (HepG2), the colorectal cancer cell line (HT-29), and breast cancer cell lines (MCF-7). The lethal effect of different ZnO NPs concentrations was assessed by sulforhodamine B sodium salt assay (SRB). The cell death percent was determined by flow cytometer, the genotoxicity was evaluated by comet assay, and the total antioxidant capacity was chemically measured. Our results show that TTFs alone cause cell death of 14, 8, and 17% of HepG2, HT-29, and MCF-7, respectively; 10 µg/mL ZnO NPs was the sub-lethal dose according to SRB results. The combination between TTFs and sub-lethal ZnO NPs increased the cell death to 29, 20, and 33% for HepG2, HT-29, and MCF-7, respectively, without reactive oxygen species increase. Increasing NPs potency using TTFs can be a novel technique in many biomedical applications.

9 June 2022 in Physics of Particles and Nuclei Letters
Verified
Journal Article
Closed access
PDF file
Alaa Abdullah El-SadiequeAlaa Abdullah El-Sadieque
Alaa Abdullah El-Sadieque
MSM. Shawki
M. Shawki
SES. Elabd
S. Elabd
MMM. Moustafa
M. Moustafa
However, the number of in vitro studies are being published regarding the cytotoxicity of nanomaterials is on the increase, the components of the media for toxicity assays have often varied according to the needs of the scientists. Our aim for this study was to: (1) evaluate the influence of serum—in this case, fetal bovine serum FBS, Phosphate Buffer Saline PBS, water for injection in a cell culture medium on the toxicity of nano-sized (20–30 nm) ZnO on human breast cancer cell line (MCF-7) and (2) use very small dose that make 50% of cancer cell death after treatment in order to the normal cells can get rid of it and be safe on body normal cells. Dispersion solution is effective factor of cell viability in presence of ZnO NPs as a treatment. The nano sized ZnO exhibited their highest toxicity when exposed to Phosphate buffer saline, in contrast to exposure in media containing 10% serum. This mainly comes from the absence of protein protection, and lower cell growth rate, but also that when we used sterilized water for injection as the dispersion solution it has an observed toxicity and a negative osmotic effect on cells that make cells increase till exploding.